Contrast Enhanced-Transrectal Ultrasound

PreclinicalSmall molecule

SSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Contrast Enhanced-Transrectal Ultrasound is one of 25 small molecule programs targeting Radiotherapy. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

RadiotherapyTerminated

RadiotherapyPreclinical

Terminated

Competition

Competitive Landscape

26 competitors in Radiotherapy

#DrugCompanyPhaseTrials

Medrol

Pfizer

Approved

1 2

Erbitux

IImclone

Phase 3

5 3

Bavencio

EMD Serono

Phase 3

3 4

Tyvyt

Innovent Biologics (Suzhou) Co. Ltd.

Phase 3

2 5

Imfinzi

AstraZeneca

Phase 2

5 6

Tecentriq

Roche

Phase 2

3 7

Eloxatin

Teva

Phase 2

2 8

Imjudo

AstraZeneca

Phase 2

2 9

Avastin

Roche

Phase 2

2 10

Abraxane

Bristol-Myers Squibb

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Radiotherapy1 trial

Contrast Enhanced Transrectal Ultrasonography (TRUS) to Assess Prostatic Vascularity After Radiotherapy (XRT)

Terminated·SSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University·N/A·NCT00635167·1 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Contrast Enhanced-Transrectal Ultrasound. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Contrast Enhanced-Transrectal Ultrasound compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Contrast Enhanced-Transrectal Ultrasound. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: SSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Contrast Enhanced-Transrectal Ultrasound

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Radiotherapy1 trial

References

Drug Info

Quick Facts

Related News